Navigation Links
Argos Therapeutics to Present Recent Clinical Developments and Corporate Overview at 18th Annual BioPartnering Europe
Date:10/8/2010

DURHAM, N.C., Oct. 8 /PRNewswire/ -- Argos Therapeutics today announced that Jeff Abbey, the company's president and chief executive officer, will present recent clinical developments and a corporate overview at the 18th Annual BioPartnering Europe conference in London at 12:15 p.m. BST on Monday, Oct. 11, 2010. The conference will take place at the Queen Elizabeth II Conference Centre.

Argos recently presented favorable progression-free survival and safety results from an ongoing Phase 2 trial for its Arcelis immunotherapy for renal cell carcinoma, AGS-003, in combination with sunitinib. The company anticipates the initiation of a large, randomized and controlled clinical study for AGS-003 in combination with sunitinib in 2011.

About the Arcelis™ Technology

Arcelis is Argos' proprietary technology for personalizing RNA-loaded dendritic cell immunotherapies for cancer, HIV and other infectious diseases. This platform is based on optimizing a patient's own (autologous) dendritic cells to trigger a tumor- or pathogen-specific immune response. To address the challenge of the unique genetic profile of each patient's disease and the genetic mutations of that disease, Argos loads the autologous dendritic cells with a sample of messenger RNA isolated from the patient's disease. Through this process, dendritic cells can potentially prime immune responses to the entire antigenic repertoire, resulting in an immunotherapeutic that is customized to the patient's specific disease.

About Argos Therapeutics, Inc.Argos is an immunotherapy company developing new treatments for cancer, infectious and autoimmune diseases and transplantation rejection. The Company has generated multiple platform technologies and a diverse pipeline of products based on its expertise in the biology of dendritic cells — the
'/>"/>

SOURCE Argos Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Results From Argos Therapeutics Arcelis™ Immunotherapy Phase 2 Study for Treatment of Renal Cell Carcinoma (RCC) Accepted for Poster Presentation at Ninth International Kidney Cancer Symposium
2. Michael R. Bristow, M.D. Ph.D. Joins Nile Therapeutics Scientific Advisory Board
3. Halozyme Therapeutics to Host Analyst Meeting on October 14 in New York
4. Prime Therapeutics Hires Peter Wickersham, Senior Vice President Cost of Care
5. Osseon® Therapeutics Introduces New Osseoflex® DR Steerable Bone Drill
6. Weikang Bio-Technology Plans to Launch New Therapeutics in First Quarter 2011
7. New American Therapeutics Acquires Antiviral Drug Denavir®
8. Nile Therapeutics to Present at BIO Investor Forum
9. Orexigen® Therapeutics to Speak at Fifth Annual JMP Securities Healthcare Conference
10. Echo Therapeutics to Present at the JMP Securities Healthcare Conference
11. Precision Therapeutics President and CEO Sean McDonald Recognized as a Leading Business Executive and Recipient of 2010 Pacesetters Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/z9s8mp/laboratory ... "Laboratory Centrifuges - Global Strategic Business Report" ... and forecasts are provided for the period 2014 ... provided for these markets. Market data and analytics ... profiles are primarily based on public domain information ...
(Date:6/2/2015)... N.C. , June 2, 2015 BioDelivery Sciences ... weather conditions, the presentation by Dr. Mark A. Sirgo ... changed to 2:30 PM Eastern time. Jefferies 2015 ... Grand Hyatt, New York City , ... can be accessed at www.bdsi.com .  For those who ...
(Date:6/2/2015)...  One hundred percent of Adventist University of Health ... graduates of April 2015 have passed the national certification ... was composed of 20 students who completed the program ... is required of every graduate in order to become ... MSNA program are eligible for state licensure as Advanced ...
Breaking Medicine Technology:Laboratory Centrifuges - Global Strategic Business Report 2014-2020: Developed Markets Slowdown, While Emerging Markets Surge 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 3ADU's Master of Science in Nurse Anesthesia April 2015 Graduates Earn 100 Percent First Time Pass Rate on National Certification Examination 2
... , , JERUSALEM ... announced today that the Data Monitoring Committee (DMC) has,independently reviewed preliminary ... ExCell) and has recommended that the JV,continue to enroll patients in ... Q2 2010. StemEx is being evaluated as a,therapeutic treatment for adolescents ...
... , , , ... , - StemEx Study is Enrolling Patients ... Hungary and Israel . , Elbit ... 28% holding on a fully diluted basis),Gamida Cell Ltd. ("Gamida Cell") through the ...
Cached Medicine Technology:Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 2Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 3Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 2Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 3Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 4Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 5
(Date:6/2/2015)... OR (PRWEB) June 02, 2015 ZOOM+, ... of ZOOM+ Performance Health Insurance, announced today the opening ... Clean White 57 - a three-in-one complete dental exam, ... Clean Jr. for kids. Like all ZOOM+ services, ZOOM+Smile ... , “Why shouldn’t the dentist office be as inviting ...
(Date:6/2/2015)... 2015 With a dedicated focus to become ... Care has hired Leslie Young as director of human ... initiatives to better understand and respond to the distinct needs ... communities in 13 states across the country. , “As we ... support to our residents, we are making it an equal ...
(Date:6/2/2015)... Alberta (PRWEB) June 02, 2015 ... wireless technology, highlights North Pole Engineering’s (NPE) announcement ... ANT Wireless technologies: WASP-N, WASP-PoE-2 and WASP-PoE-3. WASP ... ANT-FS) and Bluetooth Smart® bridge solution that allows ... transmitted over WiFi or Ethernet networks. ...
(Date:6/2/2015)... PA (PRWEB) June 02, 2015 For ... may be too exposed to harmful germs, chemicals and ... warranted. However, thanks to an inventor from Queens Village, ... SQUEEZE to provide an efficient, fun, hygienic way to ... of being exposed to bugs, chemicals and germs. Furthermore, ...
(Date:6/2/2015)... Vancouver, BC – According to ... http://www.idataresearch.com ), the bone graft substitute market is ... over traditional allograft materials. Because the use of ... increase in operation time, alternative graft options are ... these synthetic materials is partly the result of ...
Breaking Medicine News(10 mins):Health News:ZOOM+ Opens Its First On-Demand ZOOM+Smile Studio and Reinvents the Dental Exam 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 3Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 4Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 2Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 3Health News:Dental Storage and Dispensing Unit Invented by InventHelp Client (LGI-1890) 2Health News:Medtronic, DePuy Synthes Shift U.S. Bone Graft Substitute Market Towards Synthetic Demineralized Bone Matrices 2Health News:Medtronic, DePuy Synthes Shift U.S. Bone Graft Substitute Market Towards Synthetic Demineralized Bone Matrices 3
... Reporter , FRIDAY, Sept. 23 (HealthDay News) -- Fred Wyand ... of the public health response to human papillomavirus, or HPV. ... HPV News , a bimonthly newsletter published by the American ... 1990s. HPV is a sexually transmitted disease that most ...
... -- The University of South Florida School of Physical ... Department of Defense award for leading-edge musculoskeletal research intended ... military preparedness. The award will fund two major ... regimen may protect against low back injury in combat ...
... (HealthDay News) -- There is a genetic link between ... brain disorders, a new study indicates. Researchers identified ... discovered before, which play a role in people,s risk ... new insight into the causes of both conditions. ...
... By Amanda Gardner HealthDay Reporter , THURSDAY, ... arrow through the credibility of claims that a virus ... results from nine different labs around the United States ... solely on the basis of whether they tested positive ...
... The human brain doesn,t stop developing at adolescence, but continues ... of Medicine & Dentistry at the University of Alberta. ... that the human brain stopped developing in adolescence. But now ... case, thanks to medical research conducted in the Department of ...
... (SALT LAKE CITY)University of Utah biochemist Brenda L. Bass, ... less traveled. That bent hasn,t come ... distinguished professor of biochemistry who researches double-stranded RNA (dsRNA), ... fully understood. But Bass has made substantial discoveries involving ...
Cached Medicine News:Health News:Stress the 'Human' in HPV, One Man Suggests 2Health News:Stress the 'Human' in HPV, One Man Suggests 3Health News:US Department of Defense awards University of South Florida $1.59 million for musculoskeletal research 2Health News:US Department of Defense awards University of South Florida $1.59 million for musculoskeletal research 3Health News:US Department of Defense awards University of South Florida $1.59 million for musculoskeletal research 4Health News:US Department of Defense awards University of South Florida $1.59 million for musculoskeletal research 5Health News:Genetic Links Seen Between Bipolar Illness and Schizophrenia 2Health News:New Report Casts More Doubt on Virus' Link to Chronic Fatigue Syndrome 2Health News:New Report Casts More Doubt on Virus' Link to Chronic Fatigue Syndrome 3Health News:Some brain wiring continues to develop well into our 20s: U of A study 2Health News:Utah biochemist Brenda L. Bass wins NIH Pioneer Award 2Health News:Utah biochemist Brenda L. Bass wins NIH Pioneer Award 3Health News:Utah biochemist Brenda L. Bass wins NIH Pioneer Award 4
... The AVX catheter is designed ... to 12mm. High-pressure saline jets travel ... sound to create a low pressure ... is drawn into the catheter where ...
... Rheolytic Thrombectomy catheter is designed to offer ... jets create a low pressure zone around ... Thrombus is drawn into the catheter, where ... removed from the body.,AngioJet thrombectomy provides rapid ...
... System combines the legendary accuracy of the ... Windows* software. It integrates seamlessly into ... that enhance your clinical capabilities in an ... future of EP. The intended use ...
... are meeting the clinical needs of ... anesthesiologists. And, they are of the ... Medtronic.,Effective pacing with the adjustment of ... quick battery changes. Both the ...
Medicine Products: